Birjand University of Medical Sciences
Iran
Clinical Trials
243
Active:0
Completed:124
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:12
Phase 2:38
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (243 trials with phase data)• Click on a phase to view related trials
Not Applicable
110 (45.3%)Phase 3
80 (32.9%)Phase 2
38 (15.6%)Phase 1
12 (4.9%)Phase 4
2 (0.8%)Early Phase 1
1 (0.4%)Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome
Phase 4
Completed
- Conditions
- Metabolic SyndromeHypercholesterolemiaHypertriglyceridemiaHyperglycemia
- Interventions
- Drug: Saffron tabletDrug: Barberry tabletDrug: Placebo
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2012-06-21
- Lead Sponsor
- Birjand University of Medical Sciences
- Target Recruit Count
- 732
- Registration Number
- NCT01625442
- Locations
- 🇮🇷
Birjand University of medical sciences, Birjand, South khorasan, Iran, Islamic Republic of
Cupping and Serkangabin Versus Conventional Migraine Treatment
Phase 4
Completed
- Conditions
- Migraine Headache
- Interventions
- Procedure: cupping and serkangabin syrupDrug: conventional migraine drug treatment
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2014-11-24
- Lead Sponsor
- Birjand University of Medical Sciences
- Target Recruit Count
- 391
- Registration Number
- NCT01476930
- Locations
- 🇮🇷
Birjand University of Medical Sciences,Valiasr Hospital, Birjand, South Khorasan, Iran, Islamic Republic of
News
No news found